Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
9/11 | 3,150 USD
+1,61% |
+1,61% |
|
Cabaletta Bio Inc |
10/11 | 1,450 USD
-3,33% |
-3,33% |
|
Calithera Biosciences Inc |
9/11 | 0,000 USD
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
9/11 | 1,680 USD
+3,70% |
+3,70% |
|
Capricor Therapeutics Inc |
10/11 | 8,870 USD
-9,95% |
-9,95% |
Carbios |
9/11 | 5,070 EUR
+0,80% |
+0,80% |
|
Carisma Therapeutics, Inc. |
9/11 | 0,000 USD
0,00% |
0,00% |
|
Cel-Sci Corp. |
10/11 | 1,410 USD
+4,44% |
+4,44% |
|
Celldex Therapeutics Inc. |
10/11 | 30,650 USD
-1,89% |
-1,89% |
|
Cellectar Biosciences Inc |
10/11 | 1,220 USD
-4,69% |
-4,69% |
|
Cellectis |
9/11 | 1,120 USD
+4,67% |
+4,67% |
|
Cellectis |
10/11 | 1,049 EUR
-0,19% |
-0,19% |
Celyad Oncology |
10/11 | 0,170 EUR
-5,56% |
-5,56% |
|
Champions Oncology Inc |
6/11 | 4,790 USD
+0,63% |
+0,63% |
|
Co-Diagnostics Inc |
10/11 | 0,289 USD
-9,50% |
-9,50% |
|
Cogent Biosciences Inc |
9/11 | 33,540 USD
+5,99% |
+5,99% |
|
Coherus Biosciences Inc |
10/11 | 0,641 USD
-21,61% |
-21,61% |
|
CollPlant Biotechnologies Ltd |
9/11 | 4,290 USD
+8,06% |
+8,06% |
|
Compass Pathways Plc |
10/11 | 9,250 USD
+0,76% |
+0,76% |
|
Compugen Ltd. |
10/11 | 2,090 USD
-2,34% |
-2,34% |
|
Corbus Pharmaceuticals Holdings Inc |
9/11 | 3,520 USD
+14,66% |
+14,66% |
|
CRISPR Therapeutics AG |
10/11 | 45,150 USD
-9,77% |
-9,77% |
|
Cue Biopharma Inc |
9/11 | 20,140 USD
+7,53% |
+7,53% |
|
Curis Inc |
10/11 | 0,653 USD
-6,39% |
-6,39% |
|
Cytokinetics Inc |
10/11 | 56,180 USD
+1,89% |
+1,89% |
|
CytomX Therapeutics Inc |
9/11 | 1,980 USD
-9,59% |
-9,59% |